Bright Minds Biosciences Inc (NASDAQ:DRUG) does about 22.53K shares in volume on a normal day but saw 4622694 shares change hands in the recent trading day. The company now has a market cap of 6.07M USD. Its current market price is $1.36, marking an increase of 34.65% compared to the previous close of $1.01. The 52 week high reached by this stock is $2.64 whilst the lowest price level in 52 weeks is $0.93.
Bright Minds Biosciences Inc (DRUG) has a 20-day trading average at $1.0874 and the current price is -48.48% off the 52-week high compared with 46.24% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.0848 and its 200-day simple moving average is $1.3612. If we look at the stock’s price movements over the week, volatility stands at 17.11%, which decreases to 8.78% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 69.07 to suggest the stock is neutral.
The consensus objective for the share price is $45.46, suggesting that the stock has a potential upside of 97.01% over the period.
The current price level is 26.29%, 26.02%, and -0.08% away from its SMA20, SMA50, and SMA200 respectively, with the DRUG price moving below the 50-day SMA on current market day. Bright Minds Biosciences Inc (DRUG) stock is up 33.32% over the week and 13.33% over the past month. Its price is -4.90% year-to-date and -46.67% over the past year.
To reach the target analysts have set, the stock logically needs to grow 97.01 percent from here.
Outstanding shares total 3.77M with insiders holding 35.48% of the shares and institutional holders owning 4.43% of the company’s common stock. The company has a return on investment of -59.08% and return on equity of -51.16%. The beta has a value of 1.24. Price to book ratio is 1.36.
